These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 34428456

  • 1. [Knowledge and perceptions of biosimilar medicines by health professionals in Tunisia].
    Mhiri A, Khemakhem M, Kalboussi N, Kacem B.
    Ann Pharm Fr; 2022 May; 80(3):327-339. PubMed ID: 34428456
    [Abstract] [Full Text] [Related]

  • 2. Perception of hematologists and oncologists about the biosimilars: A prospective Tunisian study based on a survey.
    Hadoussa S, Bouhlel M, Soussi MA, Drira C, Hadoussa M, Khrouf MR.
    J Oncol Pharm Pract; 2020 Jan; 26(1):124-132. PubMed ID: 31106664
    [Abstract] [Full Text] [Related]

  • 3. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
    O'Callaghan J, Bermingham M, Leonard M, Hallinan F, Morris JM, Moore U, Griffin BT.
    Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
    [Abstract] [Full Text] [Related]

  • 4. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.
    Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M.
    MAbs; 2017 Aug; 9(2):383-390. PubMed ID: 27929743
    [Abstract] [Full Text] [Related]

  • 5. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.
    Adé A, Bourdon O, Bussières JF.
    Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527
    [Abstract] [Full Text] [Related]

  • 6. Awareness and Knowledge of Pharmacists toward Biosimilar Medicines: A Survey in Jordan.
    Oqal M, Hijazi B, Alqudah A, Al-Smadi A, A Almomani B, Alnajjar R, Abu Ghunaim M, Irshaid M, Husam A.
    Int J Clin Pract; 2022 Jul; 2022():8080308. PubMed ID: 35832802
    [Abstract] [Full Text] [Related]

  • 7. A nationwide survey exploring physicians' and pharmacists' knowledge, awareness and perceptions regarding generic medicines in China.
    Qu J, Zuo W, Took RL, Schafermeyer KW, Lukas S, Wang S, Du L, Liu X, Gao Y, Li J, Pan H, Du X, Mei D, Zhang B.
    BMC Health Serv Res; 2022 Aug 20; 22(1):1069. PubMed ID: 35987631
    [Abstract] [Full Text] [Related]

  • 8. Healthcare professionals' perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study.
    Aladul MI, Fitzpatrick RW, Chapman SR.
    BMJ Open; 2018 Nov 18; 8(11):e023603. PubMed ID: 30455389
    [Abstract] [Full Text] [Related]

  • 9. Knowledge, attitudes, and practices of pharmacists toward biosimilar medicines in Nigeria.
    Okoro RN, Hedima EW, Aguiyi-Ikeanyi CN.
    J Am Pharm Assoc (2003); 2022 Nov 18; 62(1):79-85.e2. PubMed ID: 34654651
    [Abstract] [Full Text] [Related]

  • 10. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
    Marín-Jiménez I, Carrascosa JM, Guigini MA, Monte-Boquet E.
    Farm Hosp; 2021 Jul 07; 45(5):240-246. PubMed ID: 34806583
    [Abstract] [Full Text] [Related]

  • 11. Patients' beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch.
    Gasteiger C, Lobo M, Dalbeth N, Petrie KJ.
    Rheumatol Int; 2021 Jan 07; 41(1):163-171. PubMed ID: 32300866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biosimilar perceptions among autoimmune prescribers and pharmacists in health system specialty pharmacy.
    Giavatto C, Mourani J, Fitzpatrick C, Hardin B, Skrtic A, Evans A, Sredzinski E, Trieu S, Setter AI, Kobiska L, Lopez-Medina AI.
    J Manag Care Spec Pharm; 2024 Feb 03; 30(2):175-182. PubMed ID: 38308629
    [Abstract] [Full Text] [Related]

  • 14. [Knowledge about Biosimilars in Primary Care: a study by the Spanish Society of Primary Care Physicians (SEMERGEN)].
    Micó-Pérez RM, Payares-Herrera C, Palomo-Jiménez PI, Sánchez-Fierro J, Avendaño-Solá C, Llisterri-Caro JL.
    Semergen; 2018 Sep 03; 44(6):380-388. PubMed ID: 29459003
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Knowledge and attitudes of physicians and pharmacists towards the use of generic medicines in Bosnia and Herzegovina.
    Čatić T, Avdagić L, Martinović I.
    Med Glas (Zenica); 2017 Feb 01; 14(1):25-32. PubMed ID: 27917846
    [Abstract] [Full Text] [Related]

  • 17. Branded versus generic drug use in chronic disease management in Hong Kong-perspectives of health care professionals and the general public.
    Lee VW, Cheng FW, Fong FY, Ng EE, Lo LL, Ngai LY, Lam AS.
    Hong Kong Med J; 2018 Dec 01; 24(6):554-560. PubMed ID: 30530869
    [Abstract] [Full Text] [Related]

  • 18. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
    Foreman E, Patel H, Siderov J, Harchowal J, Bubalo J, Chan A.
    J Oncol Pharm Pract; 2020 Apr 01; 26(3_suppl):22-32. PubMed ID: 32268828
    [Abstract] [Full Text] [Related]

  • 19. Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
    Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M, CRI (Club “Rhumatismes et Inflammations”).
    BioDrugs; 2016 Dec 01; 30(6):585-592. PubMed ID: 27848166
    [Abstract] [Full Text] [Related]

  • 20. Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians.
    Park SK, Moon W, Kim ES, Park SH, Park DI.
    Korean J Gastroenterol; 2019 Dec 25; 74(6):333-340. PubMed ID: 31870139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.